Nuclear Import of HIV-1 DNA in Resting CD4+ T Cells Requires a Cyclosporin A-Sensitive Pathway

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 512-517

  Sun, Yu ^a   Pinchuk, Lesya M ^a   Agy, Michael B ^a   Clark, Edward A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYCLOSPORIN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; VIRUS DNA;

ARTICLE; CD4+ T LYMPHOCYTE; CELL NUCLEUS; DRUG EFFECT; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INTERPHASE; LYMPHOCYTE ACTIVATION; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; BIOLOGICAL TRANSPORT; CD4-POSITIVE T-LYMPHOCYTES; CELL NUCLEUS; CYCLOSPORINE; DNA, VIRAL; HIV-1; HUMANS; INTERLEUKIN-2; INTERPHASE; LYMPHOCYTE ACTIVATION;

EID: 0030636754     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Barré, S.-F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, B.-C. Axler, B.-F. V'Ezinet, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868.
2. O'Brien, W. A., A. Namazi, H. Kalhor, S. H. Mao, J. A. Zack, and I. S. Chen. 1994. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68:1258.
3. + T cells are infectible by human immunodeficiency virus but do not release virus after activation. J. Virol. 69:5659.
4. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213.
5. Bukrinsky, M. I., T. L. Stanwick, M. P. Dempsey, and M. Stevenson. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423.
6. Spina, C. A., J. C. Guatelli, and D. D. Richman. 1995. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J. Virol. 69:2977.
7. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled al the level of T cell activation and proviral integration. EMBO J. 9:1551.
8. Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263.
9. Clark, E. A., and J. A. Ledbetter. 1994. How B and T cells talk to each other. Nature 367:425.
10. Jenkins, M. K., D. M. Pardoll, J. Mizuguchi, H. Quill, and R. H. Schwartz. 1987. T-cell unresponsiveness in vivo and in vitro: fine specificity of induction and molecular characterization of the unresponsive state. Immunol. Rev. 95:113.
11. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
12. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
13. Schwartz, R. H., D. L. Mueller, M. K. Jenkins, and H. Quill. 1989. T-cell clonal anergy. Cold Spring Harbor Symp. Quant. Biol. 2:605.
14. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy m T-cell clones. Nature 356:607.
15. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness. J. Immunol. 142:2617.
16. Liu, J. 1993. FK506 and cyclosporin: molecular probes for studying intracellular signal transduction. Trends Pharmacol. Sci. 14:182.
17. Schreiber, S. L., and G. R. Crabtree. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13:136.
18. Thompson, C. B., T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. G. Emerson, J. M. Leiden, and C. H. June. 1989, CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86:1333.
19. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporin-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472.
20. June, C. H., J. A. Ledbetter, P. S. Linsley, and C. B. Thompson. 1990. Role of the CD28 receptor in T-cell activation. Immunol. Today 11:211.
21. + T cells by the murine B7 antigen. Ear. J. Immunol. 23:283.
22. Polacino, P. S., H. A. Liang, E. J. Firpo, and E. A. Clark. 1993. T-cell activation influences initial DNA synthesis of simian immunodeficiency virus in resting T lymphocytes from macaques. J. Virol. 67:7008.
23. Polacino, P. S., H. A. Liang, and E. A. Clark. 1995. Formation of simian immunodeficiency virus long terminal repeat circles in resting T cells requires both T cell receptor-and lL-2-dependent activation. J. Exp. Med. 182:617.
24. Pinchuk, L. M., P. S. Polacino, M. B. Agy, S. J. Klaus, and E. A. Clark. 1994. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1:317.
25. Agy, M. B., M. Wambach, K. Foy, and M. G. Katze. 1990. Expression of cellular genes in CD4 positive lymphoid cells infected by the human immunodeficiency virus, HIV-1: evidence for a host protein synthesis shut-off induced by cellular mRNA degradation. Virology 177:251.
26. Sanchez-Pescador, R., M. D. Power, P. J. Barr, K. S. Steimer, M. M. Stempien, S.-S. L. Brown, W. W. Gee, A. Renard, A. Randolph, J. A. Levy, D. Dina, and P. A. Luciw. 1985. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227:484.
27. Farnet, C. M., and W. A. Haseltine. 1991. Circularization of human immunodeficiency virus type 1 DNA in vitro. J. Virol. 65:6942.
28. Gulizia, J., M. P. Dempsey, N. Sharova, M. I. Bukrinsky, L. Spitz, D. Goldfarb, and M. Stevenson. 1994. Reduced nuclear import of human immunodeficiency virus type 1 preintegration complexes in the presence of a prototypic nuclear targeting signal. J. Virol. 68:2021.
29. Zack, J. A., A. M. Haislip, P. Krogstad, and I. S. Chen. 1992. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66:1717.
30. Gao, W. Y., A. Cara, R. C. Gallo, and F. Lori. 1993. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunode-ficiency virus type 1 replication. Proc. Natl. Acad. Sci. USA 90:8925.
31. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 272: 1939.
32. ras in T lymphocytes. Cancer Surv. 22:75.
33. Polacino, P. S., L. M. Pinchuk, S. P. Sidorenko, and E. A. Clark. 1996. Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells. J. Med. Primatol. 25:201.
34. Bukrinsky, M. I., N. Sharova, M. P. Dempsey, T. L. Stanwick, A. G. Bukrinskaya, S. Haggerty, and M. Stevenson. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Prof. Natl. Acad. Sci. USA 89:6580.
35. Stevenson, M., B. Brichacek, N. Heinzinger, S. Swindells, S. Pirruccello, E. Janoff, and M. Emerman. 1995. Molecular basis of cell cycle dependent HIV-1 replication: implications for control of virus burden. Adv. Exp. Med. Biol. 374:33.
36. June, C. H., K. M. Jackson, J. A. Ledbetter, J. M. Leiden, T. Lindsten, and C. B. Thompson. 1989. Two distinct mechanisms of interleukin-2 gene expression in human T lymphocytes. J. Autoimmun. 2:55.
37. Liou, H. C., and D. Baltimore. 1993. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr. Opin. Cell Biol. 5:477.
38. Fraser, J. D., D. Straus, and A. Weiss. 1993. Signal transduction events leading to T-cell lymphokine gene expression. Immunol. Today 14:357.
39. Cullen, B. R. 1992. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:375.
40. Greene, W. C. 1990. Regulation of HIV-1 gene expression. Annu. Rev. Immunol. 8:453.
41. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. [Published erratum appears in 1990 Nature 344:178.] Nature 326:711.
42. Alcamí, J., d.-L. T. Laín, L. Folgueira, M. A. Pedraza, J. M. Jacqué, F. Bachelerie, A. R. Noriega, R. T. Hay, D. Harrich, R. B. Gaynor, J. L. Virelizier, and F. Arenzana-Seisdedos. 1995. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14:1552.
43. Kawakami, K., C. Scheidereit, and R. G. Roeder. 1988. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. Proc. Natl. Acad. Sci. USA 85:4700.
44. Antoni, B. A., A. B. Rabson, A. Kinter, M. Bodkin, and G. Poli. 1994. NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line. Virology 202:684.
45. Lai, J. H., and T. H. Tan. 1994. CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin. J. Biol. Chem. 269:30077.
46. Los, M., H. Schenk, K. Hexel, P. A. Baeuerle, W. Droge, and O.-K. Schulze. 1995. IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14:3731.
47. Schmidt, A., L. Hennighausen, and U. Siebenlist. 1990. Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner. J. Virol. 64:4037.
48. Frantz, B., E. C. Nordby, G. Bren, N. Steffan, C. V. Paya, R. L. Kincaid, M. J. Tocci, S. J. O'Keefe, and E. A. O'Neill. 1994. Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3. an inhibitor of NF-kappa B. EMBO J. 13:861.